Learn More
Apexbio Technology LLC ABT-263 (Navitoclax), 923564-51-6, MFCD12756219, 10 mg

Supplier: Apexbio Technology LLC A300710
MF: C47H55ClF3N5O6S3, MW: 974.61, Synonyms: Navitoclax, ABT-263, ABT263, ABT 263. Solubility: 48.7305mg/mL in DMSO. ABT-263 is an orally sellecitive inhibitor of B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.